President Barack Obama has nominated distinguished cardiologist and medical researcher Dr. Robert Califf to be the next U.S. Food and Drug Administration (FDA) Commissioner. The Society for Women’s Health Research (SWHR®) strongly supports his nomination to this post and urges a quick congressional confirmation.
Dr. Califf joined the FDA as deputy commissioner earlier this year from Duke University in Durham, NC, where he had served as the vice chancellor of clinical and translational research and the director of the Duke Translational Medicine Institute (DTMI). In addition, he was a professor of medicine in the Division of Cardiology at the Duke University Medical Center, and the founding director of the Duke Clinical Research Institute (DCRI).
“He is a widely respected leader in the field of clinical research and has the perspective and experience to lead the FDA during this critical juncture,” said Phyllis Greenberger, MSW, SWHR President and CEO. “We congratulate Dr. Califf on his nomination and look forward to working with him and the FDA to ensure that medical products are safe and effective for both women and minorities.”